GET DAILY SIGNALSNike (NKE): Can Shares Climb to $47 From Current Levels?
Key Takeaways
- The $47 central target is the arithmetic mean of verified analyst price targets that sit above the current share price, not a published consensus figure.
- The overall average of all valid analyst targets reviewed (about $34) sits below the current price, underscoring how cautious Wall Street remains.
- Verified targets span a wide range from roughly $19 to $51, and reaching $47 would require a substantial gain of about 21% from the latest close near $38.67.
- Supportive factors include a compressed valuation, resilient gross margins, and an aggressive cost-restructuring program.
- The biggest risks are a guided high-single-digit revenue decline for fiscal 2027 and ongoing softness in Sportswear, Jordan, and Greater China.
- Explore additional pages for NKE Major News, Today's Price Move, Forecast, and Earnings.
- Discover more AI-driven market ideas on Trending AI Robots.
What the Analyst Targets Reveal
This review looked at 24 individual, current price targets from firms including Barclays, BTIG, Guggenheim, Bernstein, RBC Capital, Baird, Stifel, UBS, JPMorgan, Deutsche Bank, Citi, Goldman Sachs, Wells Fargo, Truist, Wolfe Research, Piper Sandler, Evercore ISI, Berenberg, Morgan Stanley, BMO Capital, Bank of America, and BNP Paribas. The targets range from about $19 to $51 — an unusually wide spread that reflects genuine disagreement about the timing of a turnaround.
The arithmetic mean of all 24 targets is approximately $34, below the stock's latest price near $38.67. Because that figure falls short of the requirement to sit at least 10% above the market price, the $47 central target used here is instead the average of the six valid targets that sit above the current price: $40, $45, $45, $50, $50, and $51. That average of about $46.80 rounds to $47.
Views diverge sharply. Bulls such as Barclays ($45), BTIG ($50), and Guggenheim ($50) argue the shares are near a bottom and that fiscal 2027 guidance is achievable. Bears including BNP Paribas ($19), Bank of America ($24), and Morgan Stanley ($27) see limited visibility on a sales turnaround and continued pressure across Sportswear, Jordan, and China. This is not a uniform analyst consensus but a divided field. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Current Market Position and Path Toward the Target
At the latest close near $38.67, reaching $47 requires a gain of about 21%, a substantial move for a mega-cap consumer name. NKE reported fiscal first-quarter 2027 revenue of $11.2 billion, down 4% year over year, and guided to a high-single-digit revenue decline for the full fiscal year, with EPS guidance of $1.15 to $1.35. Gross margin still expanded 60 basis points to 42.8%.
The path to $47 would most likely require investors to begin pricing in a durable return to revenue growth — something management has not yet committed to. The company's first investor day since 2017, scheduled for November 16–17, 2026, is a key potential catalyst.
Factors That Could Support a Move Toward the Target
- Valuation reset: at roughly 18.5 times trailing earnings, the stock trades near the low end of Nike's historical range.
- Resilient gross margins and an EPS beat in the latest quarter.
- The PACE restructuring program, targeting about $2.5 billion in cumulative savings through fiscal 2031.
- Relative strength in performance categories such as running, football, tennis, and golf.
- A dividend yield of roughly 4%, supported by strong cash flow.
Risks That Could Keep the Target Out of Reach
- Management's own guidance for a high-single-digit revenue decline in fiscal 2027.
- Greater China sales fell 26% in constant currency in the latest quarter, and Converse sales fell 28%.
- Excess inventory and weaker wholesale order books in Sportswear and Jordan.
- The risk that fiscal 2028 estimates need further downward revision, keeping a lid on the multiple.
Technical Levels and Market Structure
NKE set a 52-week low near $32 in early October 2026 and has since rebounded, but it remains below its 200-day moving average near $46. The $45-to-$50 zone — where several bullish targets cluster — is the key overhead resistance level. Support sits near $32, with the psychological $40 level in between. From what I see, monitoring these levels alongside broader market moves is important.
Time Horizon and What Investors Should Monitor
Analyst price targets generally reflect a roughly 12-month horizon, though individual firms may differ. Investors should monitor the November investor day, the next earnings report, analyst revisions, and any stabilization in China and Jordan sell-through. None of these provide a guarantee that $47 will be reached. I’m watching this closely for any early signs of stabilization.
Exploring AI Daily Buy/Sell Signals
One tool I find useful for daily monitoring is AI Daily Buy/Sell Signals from Tickeron. It uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals as market conditions, technical behavior, and AI-driven analysis evolve. Rather than relying on a single indicator, the system scans for changing trends so traders can spot opportunities, monitor positions, and identify shifts in momentum more efficiently. Signals are designed to complement, not replace, traditional research and an investor's own judgment. Traders seeking a more efficient daily workflow can explore AI Daily Buy/Sell Signals to see how AI-driven monitoring might fit their routine.
Putting It Together
The $47 target represents the average of analyst targets above the current price, not a consensus forecast — the broader average of all targets is nearer $34. Reaching $47 would require a substantial advance of about 21%, driven by credible evidence of a return to growth. Supporting the case are valuation, margin resilience, and cost discipline; weighing against it are the guided sales decline, China and Jordan softness, and limited visibility on an inflection. With targets spanning $19 to $51, Wall Street is sharply divided, and investors should watch the upcoming investor day and earnings for signals rather than treating $47 as a foregone conclusion.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
NKE's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for NKE turned positive on October 08, 2026. Looking at past instances where NKE's MACD turned positive, the stock continued to rise in 25 of 43 cases over the following month. The odds of a continued upward trend are 58%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on NKE as a result. In 47 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 52%.
NKE moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for NKE crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 40%.
Following a +4.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where NKE advanced for three days, in 140 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.
The Aroon Indicator entered an Uptrend today. In 81 of 149 cases where NKE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
Bearish Trend Analysis
The 10-day RSI Indicator for NKE moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In 9 of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at 60%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NKE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
NKE broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 44 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. NKE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.859) is normal, around the industry mean (2.846). P/E Ratio (18.414) is within average values for comparable stocks, (12.010). Projected Growth (PEG Ratio) (1.427) is also within normal values, averaging (0.949). Dividend Yield (0.042) settles around the average of (0.051) among similar stocks. P/S Ratio (1.142) is also within normal values, averaging (1.162).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NKE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a maker of athletic footwear and apparel
Industry WholesaleDistributors
Advertisement